CRLBF vs. CURLF

Last updated Jun 23, 2026

CRLBF (Cresco Labs Inc) and CURLF (Curaleaf Holdings, Inc.) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. At a correlation of -0.20, they often move in opposite directions.

Performance

CRLBF vs. CURLF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cresco Labs Inc (CRLBF) and Curaleaf Holdings, Inc. (CURLF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CRLBF

• 1D: -4.94%
• 1M: -10.48%
• YTD: -37.40%
• 6M: -34.36%
• 1Y: 78.41%
• 3Y*: -21.63%
• 5Y*: -41.03%
• 10Y*: —

CURLF

• 1D: -66.67%
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRLBF vs. CURLF - Yearly Performance Comparison

	2026 (YTD)
CRLBF Cresco Labs Inc	-14.97%
CURLF Curaleaf Holdings, Inc.	-66.67%

Correlation

The correlation between CRLBF and CURLF is -0.20, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 5, 2026	-0.20

Fundamentals

Market Cap CRLBF : $280.46M CURLF : $2.82B
EPS CRLBF : -$0.39 CURLF : -$0.13
PS Ratio CRLBF : 0.42 CURLF : 2.15
PB Ratio CRLBF : 0.83 CURLF : 3.43
Total Revenue (TTM) CRLBF : $641.80M CURLF : $1.30B
Gross Profit (TTM) CRLBF : $311.73M CURLF : $528.91M
EBITDA (TTM) CRLBF : $108.21M CURLF : $188.46M

Return for Risk

CRLBF vs. CURLF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRLBF

CRLBF Risk / Return Rank: 68
CRLBF Sharpe Ratio Rank: 60
CRLBF Sortino Ratio Rank: 76
CRLBF Omega Ratio Rank: 73
CRLBF Calmar Ratio Rank: 68
CRLBF Martin Ratio Rank: 62

CURLF

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRLBF vs. CURLF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cresco Labs Inc (CRLBF) and Curaleaf Holdings, Inc. (CURLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRLBF	CURLF	Difference
Sharpe ratio: Return per unit of total volatility	0.53	—	—
Sortino ratio: Return per unit of downside risk	1.99	—	—
Omega ratio: Gain probability vs. loss probability	1.23	—	—
Calmar ratio: Return relative to maximum drawdown	1.32	—	—
Martin ratio: Return relative to average drawdown	2.10	—	—

Drawdowns

CRLBF vs. CURLF - Drawdown Comparison

The maximum CRLBF drawdown since its inception was -97.45%, which is greater than CURLF's maximum drawdown of -66.67%. Use the drawdown chart below to compare losses from any high point for CRLBF and CURLF.

Drawdown Indicators

	CRLBF	CURLF	Difference
Max Drawdown Largest peak-to-trough decline	-97.45%	-66.67%	-30.78%
Max Drawdown (1Y) Largest decline over 1 year	-59.81%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-83.90%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-96.28%	—	—
Current Drawdown Current decline from peak	-95.44%	-66.67%	-28.77%
Average Drawdown Average peak-to-trough decline	-67.74%	-66.67%	-1.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.45%	—	—

Volatility

Volatility by Period

	CRLBF	CURLF	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.20%	—	—
Volatility (6M) Calculated over the trailing 6-month period	84.29%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	150.14%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	98.30%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	89.27%	—	—

Dividends

CRLBF vs. CURLF - Dividend Comparison

Neither CRLBF nor CURLF has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

CRLBF vs. CURLF - Profitability Comparison

The chart below illustrates the profitability comparison between Cresco Labs Inc and Curaleaf Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CRLBF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cresco Labs Inc reported a gross profit of 69.55M and revenue of 149.23M. Therefore, the gross margin over that period was 46.6%.

CURLF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Curaleaf Holdings, Inc. reported a gross profit of 121.91M and revenue of 319.74M. Therefore, the gross margin over that period was 38.1%.

CRLBF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cresco Labs Inc reported an operating income of 14.63M and revenue of 149.23M, resulting in an operating margin of 9.8%.

CURLF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Curaleaf Holdings, Inc. reported an operating income of 742.57K and revenue of 319.74M, resulting in an operating margin of 0.2%.

CRLBF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cresco Labs Inc reported a net income of -12.89M and revenue of 149.23M, resulting in a net margin of -8.6%.

CURLF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Curaleaf Holdings, Inc. reported a net income of 68.83M and revenue of 319.74M, resulting in a net margin of 21.5%.

Frequently Asked Questions

Can I hold both CRLBF and CURLF in my portfolio?

CRLBF and CURLF have a correlation of -0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.